GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines

References

• Perales MA, Blachere NE, Engelhorn ME et al, Strategies to overcome immune ignorance and tolerance. Semin Cancer Biol (2002) 12: 63–71.
   Google Scholar
• Houghton AN, Cancer antigens: immune recognition of self and altered self. J Exp Med (1994) 180: 1–4.
   Google Scholar
• Boyse EA, Old LJ, Some aspects of normal and abnormal cell surface genetics. Ann Rev Genetics (1969) 3: 269–90.
   Google Scholar
• Houghton AN, Taormina MC, Ikeda H et al, Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Proc Natl Acad Sci USA (1980) 77: 4260–4.
   Google Scholar
• Houghton AN, Eisinger M, Albino AP et al, Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 156: 1755–66.
   Google Scholar
• Vijayasaradhi S, Bouchard B, Houghton AN, The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med (1990) 171: 1375–180.
   Google Scholar
• Brichard V, Van Pel A, Wolfel T et al, The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med (1993) 178: 489–95.
   Google Scholar
• Weber LW, Bowne WB, Wolchok JD et al, Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest (1998) 102: 1258–64.
   Google Scholar
• Bowne WB, Srinivasan R, Wolchok JD et al, Coupling and uncoupling of tumor immunity and autoimmunity. J Exp Med (1999) 190: 1717–22.
   Google Scholar
• Hawkins WG, Gold JS, Dyall R et al, Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity. Surgery (2000) 128: 273–180.
   PubMed Web of Science ®Google Scholar
• Dranoff G, Jaffee E, Lazenby A et al, Vaccination with irradiated tumor cells engineered to secrete murine granulocyte–macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA (1993) 90: 3539–43.
   Google Scholar
• Kielian T, Nagai E, Ikubo A et al, Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 cells leads to the local expression of macrophage inflammatory protein 1alpha and accumulation of dendritic cells at vaccination sites in vivo. Cancer Immunol Immunother (1999) 48: 123–31.
   Google Scholar
• Shinohara H, Yano S, Bucana CD, Fidler IJ, Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte–macrophage colony-stimulating factor in human colon cancer cells. J Immunol (2000) 164: 2728–37.
   Google Scholar
• Sanda MG, Ayyagari SR, Jaffee EM et al, Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol (1994) 151: 622–8.
   Google Scholar
• Dunussi-Joannopoulos K, Dranoff G, Weinstein HJ et al, Gene immunotherapy in murine acute myeloid leukemia: granulocyte–macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines. Blood (1998) 91: 222–30.
   Google Scholar
• Levitsky HI, Montgomery J, Ahmadzadeh M et al, Immunization with granulocyte–macrophage colony-stimulating factor-transduced, but not B7–1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J Immunol (1996) 156: 3858–65.
   Google Scholar
• Armitage JO, Emerging applications of recombinant human granulocyte–macrophage colony-stimulating factor. Blood (1998) 92: 4491–508.
   Google Scholar
• Kaplan G, Walsh G, Guido LS et al, Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med (1992) 175: 1717–28.
   Google Scholar
• Bowne WB, Wolchok JD, Hawkins WG et al, Injection of DNA encoding granulocyte–macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects. Cytokines Cell Mol Ther (1999) 5: 217–25.
   Google Scholar
• Ross HM, Weber LW, Wang S et al, Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization. Clin Cancer Res (1997) 3: 2191–6.
   Google Scholar
• Shibahara S, Tomita Y, Sakakura T et al, Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res (1986) 14: 2413–27.
   Google Scholar
• Bloom MB, Perry-Lalley D, Robbins PF et al, Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med (1997) 185: 453–9.
   Google Scholar
• Lemieux P, Guerin N, Paradis G et al, A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther (2000) 7: 986–91.
   Google Scholar
• Fantuzzi G, Sacco S, Ghezzi P, Dinarello CA, Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation. Am J Physiol (1997) 273: R400–6.
   Google Scholar
• Fantuzzi G, Puren AJ, Harding MW et al, Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood (1998) 91: 2118–25.
   Google Scholar
• Jager E, Ringhoffer M, Dienes HP et al, Granulocyte–macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer (1996) 67: 54–62.
   Google Scholar
• Scheibenbogen C, Schmittel A, Keilholz U et al, Phase 2 trial of vaccination with tyrosinase peptides and granulocyte–macrophage colony-stimulating factor in patients with metastatic melanoma. J Immunother (2000) 23: 275–81.
   Google Scholar
• Schaed SG, Klimek VM, Panageas KS et al, T-cell responses against tyrosinase 368–376(370D) peptide in HLA(⋆)A0201(+) melanoma patients: randomized trial comparing incomplete Freund’s adjuvant, granulocyte–macrophage colony-stimulating factor, and QS-21 as immunological adjuvants. Clin Cancer Res (2002) 8: 967–72.
   Google Scholar
• Weiss WR, Ishii KJ, Hedstrom RC et al, A plasmid encoding murine granulocyte–macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol (1998) 161: 2325–32.
   Google Scholar
• Gurunathan S, Klinman DM, Seder RA, DNA vaccines: immunology, application, and optimization. Annu Rev Immunol (2000) 18: 927–74.
   Google Scholar
• Sato Y, Roman M, Tighe H et al, Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 273: 352–4.
   Google Scholar
• Klinman DM, Yi AK, Beaucage SL et al, CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA (1996) 93: 2879–783.
   Google Scholar
• Muller CE, Mukodzi S, Reddemann H, Relationships of cytokine (GM-CSF) serum concentration to blood cell count and the inflammatory parameters in children with malignant diseases. Pediatr Hematol Oncol (1999) 16: 509–18.
   Google Scholar
• Abdelaal MA, Hashim IA, Zawawi TH et al, Circadian rhythm of granulocyte–macrophage colony-stimulating factor in normal subjects and neutropenic hospitalised patients. Ir J Med Sci (2000) 169: 55–7.
   Google Scholar
• Young MR, Matthews JP, Kanabrocki EL et al, Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte–macrophage colony-stimulating factor in men. Chronobiol Int (1995) 12: 19–27.
   Google Scholar
• Haddad D, Ramprakash J, Sedegah M et al, Plasmid vaccine expressing granulocyte–macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J Immunol (2000) 165: 3772–81.
   Google Scholar